$36.80
-0.85-2.27%
마지막 업데이트: Sep 24, 3:02 PM
Benzinga
Benzinga
Benzinga
목요일, 9월 24
Definium Therapeutics Inc
DFTXNASDAQ
Definium Therapeutics Earnings & Forecasts
Definium Therapeutics (DFTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Definium Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.56 | $-0.49 | $-0.47 | $-0.51 |
| Actual | $-1.44 | $-0.71 | $-0.50 | $-0.78 |
| Surprise | -157.1% | -44.9% | -6.38% | -52.9% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.55 | $-0.52 | $-0.48 | $-0.47 |
| Revenue | ||||
| Consensus | — | — | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved